Dysphagia in Rheumatoid Arthritis

NCT07401732 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 137

Last updated 2026-05-08

No results posted yet for this study

Summary

The primary goal of this cross-sectional study is to assess risk factors/predictors for dysphagia severity in RA.

The secondary goals include demonstrating whether flexible fiberoptic pharyngolaryngoscopy can diagnose joint-affection-induced dysphagia in patients with rheumatoid arthritis (RA) and whether both oropharyngeal and esophageal dysphagia are present among these patients.

The main questions it aims to answer are

* What are the predictors that are associated with dysphagia severity via flexible fiberoptic pharyngolaryngoscopy in rheumatoid arthritis patients?
* Whether flexible fiberoptic pharyngolaryngoscopy can diagnose joint-affection-induced dysphagia in patients with RA?
* Whether both oropharyngeal and esophageal dysphagia are present in patients with RA?

Conditions

  • Rheumatoid Arthritis (RA

Interventions

DIAGNOSTIC_TEST

flexible fiberoptic pharyngolaryngoscopy

Flexible Endoscopic Evaluations of Swallowing (FEES) will be used to examine the nose, throat, and airway to diagnose possible causes of dysphagia. The dysphagia severity scale via FEES will be scored. It is a flexible process that may be applied to a variety of situations and objectives (named as flexible pharyngolaryngoscopy). Following the routine oropharyngeal examination, its versatility can enable it to be used as a laryngoscope for examining the larynx and adjacent regions.

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • Aliaa MA Farag, MD · Tanta University Faculty of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-07
Primary Completion
2026-05-31
Completion
2026-05-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07401732 on ClinicalTrials.gov